Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
The top July 4 fireworks, festivals, and food trucks in the Triangle + Maps
Recommended
5 On Your Side shares 7 simple ways to cut down your energy bill this summer
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mereo Biopharma Group Plc ADR
(NQ:
MREO
)
3.600
+0.120 (+3.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,278,950
Open
3.470
Bid (Size)
3.470 (1)
Ask (Size)
3.600 (30)
Prev. Close
3.480
Today's Range
3.400 - 3.610
52wk Range
1.070 - 4.500
Shares Outstanding
584,908,239
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
June 14, 2024
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 12, 2024
Via
Benzinga
Performance
YTD
+56.52%
+56.52%
1 Month
+6.19%
+6.19%
3 Month
+5.57%
+5.57%
6 Month
+55.84%
+55.84%
1 Year
+183.46%
+183.46%
More News
Read More
MicroMarvel: Mereo BioPharma - Analysts Favorite
January 16, 2024
Via
Talk Markets
Uber To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Wednesday
June 12, 2024
Via
Benzinga
Why Oracle Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
June 12, 2024
Via
Benzinga
Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)
June 11, 2024
From
Ultragenyx Pharmaceutical Inc.
Via
GlobeNewswire
Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
May 30, 2024
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15, 2024
From
Mereo BioPharma Group plc
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 22, 2024
Via
Benzinga
Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
March 27, 2024
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference
March 05, 2024
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 26, 2024
Via
Benzinga
Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday
January 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
January 08, 2024
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update
October 23, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Why Is Mereo BioPharma Stock Trading Higher Today?
October 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 16, 2023
Via
Benzinga
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 16, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 16, 2023
Via
InvestorPlace
Ultragenyx and Mereo BioPharma Announce Interim Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Setrusumab (UX143) Significantly Reduced Fracture Rates in Patients with Osteogenesis Imperfecta (OI)
October 14, 2023
From
Ultragenyx Pharmaceutical Inc.; Mereo Biopharma
Via
GlobeNewswire
Ultragenyx to Present Setrusumab (UX143) Update at ASBMR 2023 Including New Data from Phase 2/3 Orbit Study in Osteogenesis Imperfecta (OI)
October 09, 2023
From
Ultragenyx Pharmaceutical Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.